Hemodialysis: Clinical Framework
Indications for Hemodialysis
Initiate hemodialysis based on clinical symptoms and signs of uremia, protein-energy wasting, or inability to manage metabolic abnormalities and volume overload medically—not on a specific GFR threshold alone. 1
For End-Stage Renal Disease (ESRD)
The decision to start maintenance dialysis should prioritize:
- Uremic symptoms: encephalopathy, pericarditis, pleuritis
- Protein-energy wasting that cannot be managed conservatively
- Metabolic derangements: refractory hyperkalemia, metabolic acidosis, hyperphosphatemia
- Volume overload unresponsive to medical therapy
Avoid initiating dialysis based solely on GFR levels in asymptomatic patients. 1 The evidence shows that early initiation (at estimated creatinine clearance 10-14 mL/min) does not reduce mortality compared to later initiation (5-7 mL/min). 2
For Acute Kidney Injury (AKI)
Absolute indications for emergency hemodialysis include 3, 4:
- Refractory hyperkalemia
- Severe volume overload unresponsive to diuretics
- Intractable metabolic acidosis
- Uremic complications (encephalopathy, pericarditis, pleuritis)
- Certain toxin removal
A BUN of 75 mg/dL can serve as a threshold for asymptomatic patients, though clinical trajectory and overall condition matter more than absolute values. 5 Recent data suggest uremia (34%) and hyperkalemia (23%) are the most common dialysis indications in cancer-associated AKI. 6
Hemodialysis Prescription and Technique
Standard Thrice-Weekly Hemodialysis
Target a single-pool Kt/V of 1.4 per session with a minimum delivered dose of 1.2 for conventional thrice-weekly hemodialysis. 1
Key prescription parameters:
- Minimum treatment time: 3 hours per session for patients with residual kidney function <2 mL/min 1
- Target Kt/V: 1.4 (minimum 1.2) for thrice-weekly schedules 1
- Standard Kt/V: 2.3 volumes/week (minimum 2.1) for alternative schedules, including ultrafiltration and residual function contributions 1
Membrane selection: Use biocompatible membranes (high or low flux). 1 High-flux membranes reduce cardiovascular mortality compared to low-flux membranes, though all-cause mortality is similar. 2
Alternative Hemodialysis Modalities
In-center frequent hemodialysis (short daily or >3×/week):
- Offer as an alternative after discussing quality of life benefits and risks 1
- Critical caveat: Increased vascular access procedures (1B evidence) and potential for intradialytic hypotension (1C evidence) 1
- Very low-quality evidence shows no mortality benefit and more access complications 2
Home long hemodialysis (6-8 hours, 3-6 nights/week):
- Consider for lifestyle preferences 1
- Risks: Increased vascular access complications, caregiver burden, accelerated loss of residual kidney function (1C evidence) 1
Special population—Pregnancy: Prescribe long frequent hemodialysis (in-center or home) for pregnant women with ESKD. 1
Monitoring and Adequacy
Volume and Blood Pressure Management
Reduce dietary sodium intake and ensure adequate sodium/water removal to control hypertension, hypervolemia, and left ventricular hypertrophy. 1
Extend treatment time or add sessions for patients with:
- Large interdialytic weight gains
- High ultrafiltration rates
- Poorly controlled blood pressure
- Difficulty achieving dry weight
- Poor metabolic control (hyperphosphatemia, acidosis, hyperkalemia) 1
Balance ultrafiltration rate to achieve euvolemia and blood pressure control while minimizing hemodynamic instability. 1
Residual Kidney Function
In patients with significant residual function (Kru), dialysis dose may be reduced, but measure Kru periodically to prevent inadequate dialysis. 1
Acute Kidney Injury Considerations
Modality Selection
For hemodynamically unstable AKI patients, continuous renal replacement therapy (CRRT) is recommended over intermittent hemodialysis (IHD). 4 However, IHD and CRRT should be viewed as complementary strategies.
CRRT Specifics
- Anticoagulation: Regional citrate anticoagulation is preferred 4
- Effluent dose: 20-25 mL/kg/hour is optimal 4
- Cessation predictor: Spontaneous diuresis is the best predictor of successful RRT discontinuation 4
Recovery Rates
In cancer-associated AKI requiring emergency dialysis, 56% achieve dialysis independence, with postrenal obstruction (37%) being the leading etiology. 6 Renal recovery has improved significantly in recent years. 6
Alternatives to Hemodialysis
Patient education at CKD stage 4 (GFR <30 mL/min/1.73 m²) must include all treatment options 1:
- Kidney transplantation (preferred when feasible)
- Peritoneal dialysis (home-based option)
- Home hemodialysis (in-center or home long/frequent)
- Conservative management (non-dialytic care)
Family members and caregivers should be included in education. 1
Common Pitfalls
Avoid initiating dialysis based solely on GFR: Clinical symptoms and trajectory matter more than numerical thresholds 1, 5
Don't assume dialysis adequacy equals adequate patient care: Hemodialysis adequacy addresses only one component; patients require comprehensive management of anemia, nutrition, bone disease, diabetes, and cardiovascular disease 1
Frequent hemodialysis increases vascular access complications: Despite theoretical benefits, more-than-thrice-weekly or extended-duration hemodialysis results in more access procedures without clear mortality benefit 1, 2
Distinguish AKI-D from ESKD status: Over 20% of in-center dialysis patients start for AKI rather than ESKD, and the transition timing has important clinical and policy implications 7
Monitor for post-dialysis complications: While advanced modalities (hemodiafiltration, hemoperfusion) may reduce inflammatory markers and improve middle-molecule clearance, short-term surrogate improvements don't necessarily translate to reduced clinical adverse events 8